Erste Asset Management GmbH »

Cartesian Therapeutics shares owned by Erste Asset Management GmbH

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Erste Asset Management GmbH from 13F filings

Historical chart of Erste Asset Management GmbH investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Erste Asset Management GmbH consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Erste Asset Management GmbH

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.8M 174k 16.14
2024-06-30 $3.3M 122k 27.05

More positions owned by Erste Asset Management GmbH

Nvidia Corporation Common Stock (NVDA)
Microsoft Corporation Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
Meta Platforms Common Stock (META)
Unitedhealth Group Incorporated Common Stock (UNH)
Netflix Common Stock (NFLX)
Visa Common Stock (V)
Adobe Common Stock (ADBE)
The Progressive Corporation Common Stock (PGR)
Broadcom Common Stock (AVGO)
Agios Pharmaceuticals Common Stock (AGIO)
Lam Research Corporation Common Stock (LRCX)
Kla Corporation Common Stock (KLAC)
Amazon.com Common Stock (AMZN)

View all positions for Erste Asset Management GmbH

Top funds holding Cartesian Therapeutics

Siren
BlackRock
BlackRock
Citadel Advisors
Jpmorgan Chase & Co
MPM Oncology Impact Management
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Erste Asset Management GmbH
State Street Corporation
Geode Capital Management
Yale University
Logos Global Management
683 Capital Management
Northern Trust

View all funds holding Cartesian Therapeutics